Stenting with Acclino (flex) for symptomatic intracranial stenosis as secondary stroke prevention

Lukas Meyer1, Hannes Leischner2, Goetz Thomalla3

  • 1Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany lu.meyer@uke.de.

Insights

Elective intracranial stenting (eICS) using a novel stent and balloon catheter combination showed acceptable safety and efficacy for secondary stroke prevention in patients with symptomatic intracranial stenosis. Further research is needed to optimize antithrombotic strategies and manage in-stent restenosis.

Area of Science:

  • Neurology
  • Interventional Neuroradiology
  • Cardiovascular Medicine

Background:

  • Symptomatic intracranial stenosis carries a high risk of stroke recurrence, even with optimal medical management.
  • Previous studies on intracranial stenting used older devices, necessitating evaluation of newer technologies.
  • Elective intracranial stenting (eICS) is reserved for a select group of high-risk patients.

Purpose of the Study:

  • To evaluate the safety and efficacy of a novel device combination for eICS in patients with symptomatic intracranial stenosis.
  • To report periprocedural complications and long-term outcomes, including stroke, death, hemorrhage, and stent patency.

Main Methods:

  • Retrospective analysis of 76 patients from three high-volume stroke centers treated with Acclino (flex) stent and NeuroSpeed balloon catheter.
  • Endpoints included periprocedural stroke or death, intracranial hemorrhage, and stent patency at follow-up.
  • Safety assessment encompassed asymptomatic/symptomatic intracranial hemorrhage and adverse events.

Main Results:

  • The periprocedural stroke or death rate was 6.5% (2.6% fatal, 3.9% non-fatal).
  • Asymptomatic intracranial hemorrhage occurred in 5.2% of patients.
  • Follow-up revealed 25% in-stent restenosis, with 11.6% requiring repeat angioplasty.

Conclusions:

  • eICS with the Acclino (flex)/NeuroSpeed system appears safe for symptomatic intracranial stenosis, offering an endovascular option for secondary stroke prevention.
  • Further studies are required to confirm these findings and optimize management of antithrombotic strategies and in-stent restenosis for long-term patency.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
189
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
151
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
186